Scary, might be so. Probably why FDA's decision was taking so long. Maybe there was a deficiency that had to be fixed, and they're getting CRL.. or maybe they're getting approval but not with a label significantly different from Botox, despite whatever data they get from the K-M curve.
News 
Market Data 
Discover 
